Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
published in: Lancet Oncology Commission
date of publication: 2014-05-13
main subject: phase III clinical trial, radium, prostate cancer
Cites articles 17
- 2004-04-01
Date
Title
Article - wd:Q38212374